Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Harvard Business School
Express Scripts
Novartis
Johnson and Johnson
Deloitte
Julphar
Chubb
Boehringer Ingelheim
Chinese Patent Office

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,602,162

« Back to Dashboard

Summary for Patent: 5,602,162
Title: Imidazole, triazole and tetrazole derivatives
Abstract:A class of substituted imidazole, triazole and tetrazole derivatives are selective agonists of 5-HT.sub.1 -like receptors and are therefore useful in the treatment of clinical conditions, in particular migraine and associated disorders, for which a selective agonist of these receptors is indicated.
Inventor(s): Baker; Raymond (Much Hadham, GB2), Matassa; Victor G. (Furneux Pelham, GB2), Street; Leslie J. (Harlow, GB2)
Assignee: Merck, Sharp & Dohme Ltd. (Hoddesdon, GB2)
Application Number:08/438,621
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 5,602,162

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,602,162

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9102222Feb 01, 1991
United Kingdom9106917Apr 03, 1991
United Kingdom9113415Jun 21, 1991
United Kingdom9122451Oct 23, 1991

International Patents Family Members for US Patent 5,602,162

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 158582 ➤ Subscribe
Australia 1068092 ➤ Subscribe
Australia 644939 ➤ Subscribe
Bulgaria 62024 ➤ Subscribe
Brazil 1100797 ➤ Subscribe
Canada 2060139 ➤ Subscribe
Canada 2238140 ➤ Subscribe
China 1038681 ➤ Subscribe
China 1060479 ➤ Subscribe
China 1061654 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Daiichi Sankyo
Citi
Queensland Health
UBS
Farmers Insurance
Medtronic
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot